Toxicity after prolonged (more than four weeks) administration of intravenous colistin

BMC Infectious Diseases

Volumn 5, Issue , 2005, Pages

  Falagas, Matthew E ^a,b,c   Rizos, Michael ^d   Bliziotis, Ioannis A ^c   Rellos, Kostas ^d   Kasiakou, Sofia K ^c   Michalopoulos, Argyris ^d  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Alfa HealthCare   (Greece)

^d HENRY DUNANT HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOTRANSFERASE; AMPHOTERICIN; COLISTIN; CREATININE; IMIPENEM; TEICOPLANIN; UREA; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; APNEA; ARTICLE; CLINICAL OBSERVATION; CREATININE BLOOD LEVEL; DATA ANALYSIS; DRUG DOSE REGIMEN; DRUG FATALITY; ENZYME DEFECT; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; GREECE; HEPATOBILIARY DISEASE; HUMAN; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LIVER TOXICITY; MOTOR NEUROPATHY; MULTIDRUG RESISTANCE; MYOPATHY; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR DISEASE; NEUROTOXICITY; NONHUMAN; POLYNEUROPATHY; SENSORY NEUROPATHY; SYMPTOMATOLOGY; UREA BLOOD LEVEL; ADOLESCENT; ADULT; AGED; BACTEREMIA; BACTERIAL INFECTION; BLOOD; COHORT ANALYSIS; DRUG EFFECT; FEMALE; HEPATOBILIARY SYSTEM; INFUSION PUMP; KIDNEY; LIVER; MALE; MIDDLE AGED; NERVOUS SYSTEM; NEUROMUSCULAR SYNAPSE; PNEUMONIA; RETROSPECTIVE STUDY; TIME;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL INFECTIONS; BILIARY TRACT; COHORT STUDIES; COLISTIN; CREATININE; FEMALE; HUMANS; INFUSION PUMPS; KIDNEY; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; NERVOUS SYSTEM; NEUROMUSCULAR JUNCTION; PNEUMONIA; RETROSPECTIVE STUDIES; TIME FACTORS; UREA;

EID: 17644362912     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-5-1     Document Type: Article

References (14)

1. Conway SP, Etherington C, Munday J, Goldman MH, Strong JJ, Wootton M: Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis. Ann Pharmacother 2000, 34(11):1238-1242.
2. Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE: Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med 1970, 72(6):857-868.
3. Flanagan AD: Adverse effects of sodium colistimethate. Ann Intern Med 1971, 74(1):143-144.
4. Randall RE, Bridi GS, Setter JG, Brackett NC: Recovery from colistimethate nephrotoxicity. Ann Intern Med 1970, 73(3):491-492.
5. Michalopoulos A, Tsiodras S, Rellos K, Melentzopoulos S, Falagas ME: Colistin treatment in patients with ICU-acquired infections due to multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 2005 in press.
6. Levin AS, Barone AA, Penco J, Santos MV, Marinho IS, Arruda EA, et al.: Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 1999, 28(5):1008-1011.
7. Linden PK, Kusne S, Coley K, Fontes P, Kramer DJ, Paterson D: Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis 2003, 37(11):e154-e160.
8. Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos I, et al.: Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care 2003, 7(5):R78-R83.
9. Gaynes RP, Horan TC: Surveillance of nosocomial infections. Appendix A: CDC definitions of nosocomial infections. In Hospital epidemiology and infection control Edited by: Mayhall CG. Baltimore: Williams & Wilkins; 1996:1-14.
10. Ryan KJ, Schainuck LI, Hickman RO, Striker GE: Colistimethate toxicity. Report of a fatal case in a previously healthy child. JAMA 1969, 207(11):2099-2101.
11. Price DJ, Graham DI: Effects of large doses of colistin sulphomethate sodium on renal function. Br Med J 1970, 4(734):525-527.
12. Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar AE, Garcia-Garmendia JL, Bernabeu-WittelI M, et al.: Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 2003, 36(9):1111-1118.
13. Stein A, Raoult D: Colistin: an antimicrobial for the 21st century? Clin Infect Dis 2002, 35(7):901-902.
14. Falagas ME, Kasiakou SK: Colistin: the revival of polymixins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005.